These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 6112039

  • 21. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
    Nelson GI, Silke B, Barker MC, Saxton CA, Taylor SH.
    Eur Heart J; 1982 Jun; 3(3):238-45. PubMed ID: 6125392
    [No Abstract] [Full Text] [Related]

  • 22. Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'.
    Derksen FJ, Olszewski M, Robinson NE, Berney C, Lloyd JW, Hakala J, Matson C, Ruth D.
    Equine Vet J; 1996 Jul; 28(4):306-10. PubMed ID: 8818596
    [Abstract] [Full Text] [Related]

  • 23. Effects of prolonged administration of pirbuterol by mouth in chronic asthma.
    Paterson IC, Willey RF, Grant IW.
    Br J Clin Pharmacol; 1977 Jun; 4(3):376-7. PubMed ID: 20120
    [No Abstract] [Full Text] [Related]

  • 24. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
    Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R.
    N Z Med J; 1990 Jun 13; 103(891):259-61. PubMed ID: 1972557
    [Abstract] [Full Text] [Related]

  • 25. Acute and long-term hemodynamic effects of oral pirbuterol in patients with chronic severe congestive heart failure: randomized double-blind trial.
    Pamelia FX, Gheorghiade M, Beller GA, Bishop HL, Olukotun AY, Taylor CR, Watson DD, Grunwald AM, Sirowatka J, Carabello BA.
    Am Heart J; 1983 Dec 13; 106(6):1369-76. PubMed ID: 6359846
    [Abstract] [Full Text] [Related]

  • 26. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
    Awan NA, Needham K, Evenson MK, Hermanovich J, Joye JA, DeMaria AN, Mason DT.
    Am Heart J; 1981 Sep 13; 102(3 Pt 2):555-63. PubMed ID: 7270402
    [No Abstract] [Full Text] [Related]

  • 27. Effects of oral and inhaled salbutamol and oral pirbuterol on right and left ventricular function in chronic bronchitis.
    Winter RJ, Langford JA, Rudd RM.
    Br Med J (Clin Res Ed); 1984 Mar 17; 288(6420):824-5. PubMed ID: 6142748
    [Abstract] [Full Text] [Related]

  • 28. Clinical efficacy of two beta 2-sympathicomimetics in different inhalers in children with asthma. Comparison of pirbuterol in a breath-actuated inhaler and salbutamol in a customary metered-dose inhaler.
    Völkl KP, Kroll VM, Wiesemann HG, Schneider B.
    Arzneimittelforschung; 1991 May 17; 41(5):533-6. PubMed ID: 1680327
    [Abstract] [Full Text] [Related]

  • 29. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS.
    J Clin Invest; 1985 Feb 17; 75(2):643-9. PubMed ID: 3973022
    [Abstract] [Full Text] [Related]

  • 30. Management of severe chronic CHF with oral pirbuterol.
    Awan NA, Needham K, Evenson MK, Mason DT.
    Acta Med Scand Suppl; 1981 Feb 17; 652():155-62. PubMed ID: 6949462
    [No Abstract] [Full Text] [Related]

  • 31. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
    Richards DM, Brogden RN.
    Drugs; 1985 Jul 17; 30(1):6-21. PubMed ID: 2863125
    [Abstract] [Full Text] [Related]

  • 32. Clinicopharmacological studies of a newly synthesized cardiotonic agent (TA-064) in patients with congestive heart failure.
    Bito K, Kinoshita M, Mashiro I, Ozaki N, Sakoda S, Tsutamoto T, Motomura M, Mitsunami K, Fukuhara T, Kawakita S.
    Clin Cardiol; 1988 May 17; 11(5):334-9. PubMed ID: 3383472
    [Abstract] [Full Text] [Related]

  • 33. The haemodynamic responses to incremental doses of intravenous nitroglycerin in left ventricular failure.
    Bayley S, Valentine H, Bennett ED.
    Intensive Care Med; 1984 May 17; 10(3):139-45. PubMed ID: 6429221
    [Abstract] [Full Text] [Related]

  • 34. [Positive inotropic agents. Generalities and classification].
    Vahanian A, Le Potier J, Sergent J, Michel PL, Acar J.
    Ann Med Interne (Paris); 1985 May 17; 136(3):242-6. PubMed ID: 2862822
    [Abstract] [Full Text] [Related]

  • 35. Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD.
    Neilly JB, Carter R, Tweddel A, Martin W, Hutton I, Banham SW, Stevenson RD.
    Respir Med; 1989 Jan 17; 83(1):59-65. PubMed ID: 2511610
    [Abstract] [Full Text] [Related]

  • 36. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ, Tashkin DP, Ho D, Child JS.
    Ann Allergy; 1979 Oct 17; 43(4):229-36. PubMed ID: 555600
    [Abstract] [Full Text] [Related]

  • 37. Haemodynamic changes in heart failure induced by a new vasodilator tolmesoxide.
    Lauwers P, Nievel JG.
    Eur J Clin Pharmacol; 1982 Oct 17; 21(6):473-7. PubMed ID: 7075653
    [Abstract] [Full Text] [Related]

  • 38. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices.
    Tinkelman DG, Lutz C.
    Ann Allergy; 1992 Jan 17; 68(1):23-6. PubMed ID: 1346562
    [Abstract] [Full Text] [Related]

  • 39. [A study on tolerance to denopamine, oral beta 1-agonist].
    Hondo T, Kawagoe T, Morichika N, Nakagawa H, Yamagata T, Yuasa A, Tsuchioka Y, Matsuura H, Kajiyama G, Okamoto M.
    Kokyu To Junkan; 1990 Sep 17; 38(9):875-80. PubMed ID: 1978386
    [Abstract] [Full Text] [Related]

  • 40. [Treatment of severe congestive heart failure with the beta-agonist fenoterol (author's transl)].
    Irmer M, Wollschläger H, Just H.
    Klin Wochenschr; 1981 Jun 15; 59(12):639-45. PubMed ID: 6114186
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.